ACB - Aurora Cannabis Inc. (NasdaqCM) - Share Price and News

Aurora Cannabis Inc.
US ˙ NasdaqCM ˙ CA05156X8843

Overview
Aurora Cannabis Inc., headquartered in Edmonton, Canada, is a prominent company within the global cannabis industry, engaging in the cultivation, distribution, and sale of medical and consumer cannabis products. Primarily known for its high-grade medicinal cannabis, Aurora has expanded its operations to include a diverse range of cannabis product lines, encompassing both dry cannabis and derivative products such as oils and capsules. The company has strategically positioned itself in both the domestic and international markets through the acquisition of leading competitors and by establishing significant production capabilities. Key projects have focused on expanding its production efficiency and scale, enhancing its research on cannabis for medical purposes, and increasing its footprint in strategic international markets to capitalize on evolving legal landscapes and growing consumer demand for cannabis-based products.
Basic Stats

The share price of Aurora Cannabis Inc. as of September 5, 2025 is $4.90 / share. This is a decrease of -9.59% from the prior week. The market cap (or net worth) of Aurora Cannabis Inc. as of September 5, 2025 is $275.64 MM.

The Factor Analysis chart (below right) shows a view of Aurora Cannabis Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.

For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.

Market Cap 275.64 MM
EV
Shares Out. 56.25 MM
Earnings Date
EPS (TTM) -0.32
Dividend Yield
Ex-Dividend Date
Borrow Rate 4.64
Short Shares Avail. 0.85 MM
Short Interest 5.90 MM
Short Float 10.50 %
Days to Cover 5.71 days
Risk Free Rate 4.22 %
Price Change (1 yr) -12.50 %
Volatility (1 yr) 0.80
Beta 1.30
Sharpe Ratio (1 yr) -0.21
Sortino Ratio (1 yr) -0.42
PE Ratio
Price/Book
Price/TBV
Book/Market
EBIT/EV
EBIT(3yr avg)/EV
ROA -0.02
ROE -0.03
ROIC -0.02
CROIC 0.00
OCROIC 0.02
Implied Volatility 97.78  %
Put/Call OI Ratio 0.37
Growth
Profitability
Quality Score
Value Score
Momentum Score
Stability (Low Vol) Score
Analyst Sentiment
Fund Sentiment
Insider Sentiment
Officer Sentiment
Dividend Score
QVM Score
Piotroski F-SCORE 3.00 /9
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target

The average one-year price target for Aurora Cannabis Inc. is $5.80. The forecasts range from a low of $4.35 to a high of $7.53. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.

Update Frequency: Monthly

Record Date Projection Date High Low Median Average
2025-08-22 2026-08-22 7.53 4.35 5.74 5.80
Stock Upgrades/Downgrades

This card shows analyst upgrades/downgrades for Aurora Cannabis Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.

The standard analyst ratings are generally as follows:
  • Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
  • Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
  • Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.

When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.

The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.

Date Analyst Prior Latest
Recommendation
Action
2023-11-16 CIBC CAPITAL MARKETS Neutral Neutral Maintains
2023-11-10 ROTH MKM Neutral Neutral Maintains
2023-11-09 PIPER SANDLER COMPANIES Neutral Neutral Maintains
2023-08-28 CIBC CAPITAL MARKETS Neutral Neutral Maintains
2023-08-27 CIBC CAPITAL MARKETS Neutral Neutral Maintains
2023-08-26 ROTH MKM Neutral Neutral Maintains
2023-08-25 ROTH MKM Neutral Neutral Maintains
2023-08-10 PIPER SANDLER COMPANIES Neutral Neutral Maintains
2023-08-09 PIPER SANDLER COMPANIES Neutral Neutral Maintains
2023-02-12 CIBC CAPITAL MARKETS Underperform Neutral Upgrade
2023-02-12 STIFEL NICOLAUS AND COMPANY, INCORPORATED Sell Hold Upgrade
2023-02-11 CIBC CAPITAL MARKETS Underperform Neutral Upgrade
2023-02-11 STIFEL NICOLAUS AND COMPANY, INCORPORATED Sell Hold Upgrade
2023-02-10 ROTH MKM Neutral Neutral Maintains
2023-02-09 ROTH MKM Neutral Neutral Maintains
2023-02-09 PIPER SANDLER COMPANIES Neutral Neutral Maintains
2023-02-08 PIPER SANDLER COMPANIES Neutral Neutral Maintains
2022-12-13 MKM PARTNERS Sell Neutral Upgrade
2022-12-12 MKM PARTNERS Sell Neutral Upgrade
2022-11-11 STA Research Buy Maintains
2022-11-11 CIBC Capital Markets Neutral Maintains
2022-10-28 STA Research Buy Reiterate
2022-10-14 STA Research Buy Maintains
2022-09-21 CANTOR FITZGERALD Neutral Overweight Upgrade
2022-09-20 CANTOR FITZGERALD Neutral Overweight Upgrade
2022-09-20 ATB CAPITAL MARKETS Underperform Underperform Maintains
2022-09-19 ATB CAPITAL MARKETS Underperform Underperform Maintains
2022-09-16 STA Research Buy Reiterate
2022-08-23 STA Research Buy Reiterate
2022-07-19 Cowen 1.85 2 Upgrade
2022-06-24 STA Research Buy Maintains
2022-06-13 CANTOR FITZGERALD Neutral Neutral Maintains
2022-06-12 CANTOR FITZGERALD Neutral Neutral Maintains
2022-05-13 MKM Partners Hold Reiterate
2022-05-13 Cantor Fitzgerald Securities Hold Initiate
2022-05-12 STIFEL NICOLAUS AND COMPANY, INCORPORATED Sell Sell Maintains
2022-05-11 STIFEL NICOLAUS AND COMPANY, INCORPORATED Sell Sell Maintains
2022-03-28 STA Research Buy Reiterate
2022-03-23 CIBC Capital Markets Neutral Maintains
2022-03-02 STA Research Speculative Buy Maintains
2022-03-02 Morningstar Buy Initiate
2022-02-17 NEEDHAM & COMPANY INC. Underperform Underperform Maintains
2022-02-16 NEEDHAM & COMPANY INC. Underperform Underperform Maintains
2022-02-11 Piper Sandler Hold Initiate
2022-02-11 CIBC Capital Markets Neutral Maintains
2022-01-27 CIBC Capital Markets Buy Initiate
2021-11-15 BRYAN GARNIER Sell Sell Maintains
2021-11-14 BRYAN GARNIER Sell Sell Maintains
2021-11-11 CanaccordFinancials Hold Maintains
2021-11-04 CIBC CAPITAL MARKETS Neutral Underperform Downgrade
2021-11-04 CM Bank Underperform Maintains
2021-11-03 CIBC CAPITAL MARKETS Neutral Underperform Downgrade
2021-10-01 Jefferies Hold Maintains
2021-09-28 Piper Sandler Hold Reiterate
2021-09-24 CIBC World Markets Underperform Maintains
2021-07-09 DESJARDINS SECURITIES Sell Sell Maintains
2021-07-08 DESJARDINS SECURITIES Sell Sell Maintains
2021-05-14 MKM PARTNERS Sell Sell Maintains
2021-05-14 ATB Capital Sector Perform Underperform Downgrade
2021-05-13 MKM PARTNERS Sell Sell Maintains
2021-05-11 CIBC World Markets Neutral Underperform Downgrade
2021-04-22 CIBC CAPITAL MARKETS Neutral Neutral Maintains
2021-04-21 CIBC CAPITAL MARKETS Neutral Neutral Maintains
2021-02-24 Jefferies 4.59 9.44 Upgrade
2021-02-12 Stifel Nicolaus 6.5 7.8 Upgrade
2021-02-12 MKM Partners Sell Reiterate
2021-02-12 Canaccord Genuity 11 14 Upgrade
2021-02-08 CIBC World Markets 15 17 Upgrade
2020-12-18 BMO Capital Market Perform Underperform Downgrade
2020-11-17 ATB Capital Underperform Sector Perform Upgrade
2020-11-10 Cowen 10 16 Upgrade
2020-11-10 CIBC World Markets 12 15 Upgrade
2020-10-28 Stifel Nicolaus 10.5 3.6 Downgrade
2020-09-24 CIBC World Markets 20 12 Downgrade
2020-09-23 ATB Capital 11.3 10.25 Downgrade
2020-09-23 Cowen 11 10 Downgrade
2020-09-23 MKM Partners 18 9 Downgrade
2020-09-23 Piper Sandler Neutral Maintains
2020-09-21 Canaccord Genuity 21 10 Downgrade
2020-09-09 Stifel Nicolaus 16 10.5 Downgrade
2020-09-09 ATB Capital 10.4 11.3 Upgrade
2020-09-08 Ladenburg Thalmann Buy Neutral Downgrade
2020-08-18 CIBC World Markets 24 20 Downgrade
2020-06-24 Canaccord Genuity 24 21 Downgrade
2020-06-24 Stifel Nicolaus Sell Hold Upgrade
2020-05-28 Altacorp Capital 2.5 10.4 Upgrade
2020-05-25 CIBC World Markets 14 24 Upgrade
2020-05-19 MKM Partners 12 18 Upgrade
2020-05-19 CIBC World Markets 27 14 Downgrade
2020-05-19 Canaccord Genuity 27 24 Downgrade
2020-05-18 Cowen 12 11 Downgrade
2020-05-15 Piper Sandler Underweight Neutral Upgrade
2020-05-12 Cowen 30 12 Downgrade
2020-05-12 Eight Capital 2 11 Upgrade
2020-04-16 Jefferies 1.9 1 Downgrade
2020-03-16 MKM Partners 1.75 1 Downgrade
2020-02-25 Needham Hold Initiate
2020-02-16 CIBC World Markets 2.5 2.25 Downgrade
2020-02-14 Canaccord Genuity 3 2.25 Downgrade
2020-02-10 PI Financial Buy Neutral Downgrade
2020-02-10 CIBC World Markets 5 2.5 Downgrade
2020-02-07 Stifel Nicolaus 1.75 1 Downgrade
2020-02-07 Eight Capital Buy Neutral Downgrade
2020-02-07 Canaccord Genuity Speculative Buy Hold Downgrade
2020-01-10 Piper Sandler Neutral Underweight Downgrade
2020-01-10 B of A Securities Buy Neutral Downgrade
2019-12-24 Jefferies Buy Hold Downgrade
2019-12-16 Laurentian Bank Buy Initiate
2019-11-16 Cantor Fitzgerald Neutral Overweight Upgrade
2019-11-05 Cantor Fitzgerald Neutral Reiterate
2019-10-22 Piper Jaffray Neutral Maintains
2019-10-11 Jefferies 14 7 Downgrade
2019-09-24 CIBC World Markets Neutral Initiate
2019-09-20 MKM Partners Sell Initiate
2019-09-16 Stifel Nicolaus Hold Sell Downgrade
2019-09-16 Stifel Hold Sell Downgrade
2019-07-18 Bank of America Buy Neutral Downgrade
2019-07-17 Ladenburg Thalmann Buy Initiate
2019-06-06 Stifel Nicolaus Hold Initiate
2019-05-03 Jefferies 12 14 Upgrade
2019-04-26 Desjardins Buy Initiate
2019-04-17 Bank of America Buy Initiate
2019-03-05 Cowen Outperform Initiate
2019-03-05 Cowen & Co. Outperform Initiate
2019-02-25 Jefferies Buy Initiate
2019-02-21 Seaport Global Neutral Initiate
2019-01-09 Eight Capital 17 15 Downgrade
2018-09-26 Canaccord Genuity 11 13 Upgrade
2018-08-02 Eight Capital Buy Initiate
2018-04-18 Canaccord Genuity Hold Speculative Buy Upgrade
2018-03-16 Canaccord Genuity Speculative Buy Hold Downgrade
2017-11-13 Canaccord Genuity 3.65 4.45 Upgrade
2016-11-02 Canaccord Genuity Speculatie Buy Maintains
2024-08-07 ROTH MKM Neutral Neutral Maintains
2024-06-19 CIBC CAPITAL MARKETS Neutral Neutral Maintains
2024-08-06 ROTH MKM Neutral Neutral Maintains
2024-06-18 CIBC CAPITAL MARKETS Neutral Neutral Maintains
2023-11-15 CIBC CAPITAL MARKETS Neutral Neutral Maintains
2023-11-09 ROTH MKM Neutral Neutral Maintains
2023-11-08 PIPER SANDLER COMPANIES Neutral Neutral Maintains
2025-02-09 CANACCORD GENUITY Buy Buy Maintains
2025-02-06 TD COWEN Buy Buy Maintains
2025-02-05 ROTH CAPITAL PARTNERS Neutral Neutral Maintains
2025-02-05 ZUANIC & ASSOCIATES Neutral Neutral Maintains
2024-12-12 TD COWEN Buy Buy Maintains
2024-12-09 ZUANIC & ASSOCIATES Neutral Neutral Maintains
2024-11-06 ROTH MKM Neutral Neutral Maintains
2024-11-05 CANACCORD GENUITY Buy Buy Maintains
2025-06-25 TD COWEN Buy Buy Maintains
2025-06-18 ROTH CAPITAL PARTNERS Neutral Neutral Maintains
2025-06-17 ATB CAPITAL MARKETS Underperform Outperform Upgrade
2025-04-09 ZUANIC & ASSOCIATES Neutral Neutral Maintains
Other Listings
BG:21P
CA:ACB CA$6.69
DE:21P
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista